Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)
- PMID: 25176145
- DOI: 10.1002/pbc.25208
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH)
Abstract
Background: There are no population-based surveillance systems to determine prevalence, impact or outcomes in sickle cell disease (SCD). Estimates of the SCD population in California range broadly from 4,500 to 7,000, and little is known about their health status, health care utilization or health outcomes. A surveillance strategy was implemented using diverse data sources to develop a multi-dimensional, state-based surveillance system for SCD that includes adults and children and describes utilization, treatment and outcomes.
Procedure: Data from California newborn screening, inpatient and emergency room records, Medi-Cal/Medicaid claims and two SCD special care centers were collected for 2004-2008. A multi-step, iterative linkage process was used to link and de-duplicate these data sources, and case definitions were used to categorize cases.
Results: After linking and de-duplicating, there were 1,975 confirmed cases of SCD, 3,159 probable cases as well as 8,024 possible cases. Among individual data sources, newborn screening and data from clinics contributed the greatest number of unique cases to the total. Select analyses of utilization and treatments for the population are described.
Conclusions: Using linked existing data sources, an estimate of the statewide count of the SCD population is possible. The approach can be used to create an in-depth health status profile of the affected population by aggregating utilization, treatment, and outcomes data including mortality and morbidity information. This effort sets the stage for development of an on-going, state-based surveillance system.
Keywords: California; data linkage; public health surveillance; sickle cell disease.
© 2014 Wiley Periodicals, Inc.
Similar articles
-
Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.MMWR Surveill Summ. 2022 Oct 7;71(9):1-18. doi: 10.15585/mmwr.ss7109a1. MMWR Surveill Summ. 2022. PMID: 36201430 Free PMC article.
-
A method to identify California's sickle-cell disease population and its linkage to the California Cancer Registry.J Registry Manag. 2012 Summer;39(2):53-61. J Registry Manag. 2012. PMID: 23599029
-
The Prevalence of Sickle Cell Disease in Colorado and Methodologies of the Colorado Sickle Cell Data Collection Program: Public Health Surveillance Study.JMIR Public Health Surveill. 2024 Dec 9;10:e64995. doi: 10.2196/64995. JMIR Public Health Surveill. 2024. PMID: 39652892 Free PMC article.
-
Administrative data sets and health services research on hemoglobinopathies: a review of the literature.Am J Prev Med. 2010 Apr;38(4 Suppl):S557-67. doi: 10.1016/j.amepre.2009.12.015. Am J Prev Med. 2010. PMID: 20331958 Review.
-
History and current status of newborn screening for hemoglobinopathies.Semin Perinatol. 2010 Apr;34(2):134-44. doi: 10.1053/j.semperi.2009.12.006. Semin Perinatol. 2010. PMID: 20207263 Review.
Cited by
-
Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.Br J Haematol. 2019 Apr;185(1):116-127. doi: 10.1111/bjh.15773. Epub 2019 Feb 3. Br J Haematol. 2019. PMID: 30714090 Free PMC article.
-
Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.Blood Adv. 2017 Jul 11;1(16):1287-1295. doi: 10.1182/bloodadvances.2017005256. eCollection 2017 Jul 11. Blood Adv. 2017. PMID: 29296770 Free PMC article.
-
Hematologist encounters among Medicaid patients who have sickle cell disease.Blood Adv. 2022 Sep 13;6(17):5128-5131. doi: 10.1182/bloodadvances.2022007622. Blood Adv. 2022. PMID: 35819456 Free PMC article. No abstract available.
-
Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.Health Sci Rep. 2021 Jul 14;4(3):e323. doi: 10.1002/hsr2.323. eCollection 2021 Sep. Health Sci Rep. 2021. PMID: 34277954 Free PMC article.
-
Pregnancy outcomes in women with sickle cell disease in California.Am J Hematol. 2023 Mar;98(3):440-448. doi: 10.1002/ajh.26818. Epub 2023 Jan 4. Am J Hematol. 2023. PMID: 36594168 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical